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Enterobacterial common antigen (ECA) is a polysaccharide present in all members of
Enterobacteriaceae anchored either via phosphatidylglycerol (PG) or LPS to the outer leaflet of
the outer membrane (ECAPG and ECALPS, respectively). Only the latter form is ECA-
immunogenic. We previously demonstrated that Yersinia enterocolitica O : 3 and its rough (O-
specific polysaccharide-negative) mutants were ECA-immunogenic, suggesting that they
contained ECALPS; however, it was not known which part of the LPS core region was involved in
ECA binding. To address this, we used a set of three deep-rough LPS mutants for rabbit
immunization. The polyvalent antisera obtained were: (i) analysed for the presence of anti-LPS and
anti-ECA antibodies; (ii) treated with caprylic acid (CA) to precipitate IgM antibodies and protein
aggregates; and (iii) adsorbed with live ECA-negative bacteria to obtain specific anti-ECA
antisera. We demonstrated the presence of antibodies specific for both ECAPG and ECALPS in all
antisera obtained. Both CA treatment and adsorption with ECA-negative bacteria efficiently
removed anti-LPS antibodies, resulting in specific anti-ECA sera. The LPS of the ECALPS-positive
deepest-rough mutant contained only lipid A and 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo)
residues of the inner core, suggesting that ECALPS was linked to the Kdo region of LPS in Y.
enterocolitica O : 3.
INTRODUCTION
LPS is an important component of most Gram-negative
bacterial cell envelopes and can be involved in a broad
range of physiological and pathological activities associated
with the human host immune system (Meredith et al.,
2006). In wild-type strains the smooth (S) form of LPS
molecule consists of lipid A (LA) to which is covalently
linked a heteropolysaccharide chain made up of a core
oligosaccharide (OS) and an O-specific polysaccharide
(OPS). Rough-type bacteria (R) produce LPS lacking OPS
(Alexander & Rietschel, 2001; Chung & Raetz, 2010). In
Salmonella enterica serovar Minnesota, inactivation of
3These authors contributed equally to this work.
Abbreviations: CA, caprylic acid; DOC-PAGE, deoxycholate PAGE; ECA,
enterobacterial common antigen; ECACYC, cyclic enterobacterial com-
mon antigen; ECALPS, LPS-bound enterobacterial common antigen;
ECAPG, phosphatidylglycerol-bound enterobacterial common antigen;
ESI, electrospray ionization; Kdo, 3-deoxy-D-manno-oct-2-ulopyrano-
sonic acid; LA, lipid A; M164, strain YeO3-c-R1-M164; M196, strain
YeO3-c-R1-M196; M205, strain YeO3-c-R1-M205; OPS, O-specific
polysaccharide; OS, core oligosaccharide; PCP, phenol/chloroform–light
petroleum; PG, phosphatidylglycerol; WB, Western blotting; WCL, whole-
cell lysate; YeO3, Yersinia enterocolitica O : 3.
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different core biosynthetic genes resulted in gradually
truncated core structures known as the Ra, Rb, Rc, Rd and
Re chemotypes. Ra mutants synthesize full-core OS, while
Rb to Rd mutants contain cores with a decreasing number
of monosaccharide residues, down to Re mutants which
contain only two 3-deoxy-D-manno-oct-2-ulosonic acid
(Kdo) residues and LA in their LPS. Other members of
Enterobacteriaceae form similar but not identical rough
core structures (Seltmann & Holst, 2001; Focà et al., 2012).
Bacilli from the genus Yersinia were earlier classified within
the genus Pasteurella (Pasteurellaceae). The identification
of enterobacterial common antigen (ECA) in their cell
envelope resulted in their reclassification to Enterobac-
teriaceae (Kuhn et al., 1988). Yersinia enterocolitica O : 3
(YeO3) is a rod-shaped, Gram-negative, non-sporulating,
facultatively anaerobic and oxidase-negative human patho-
gen (Bottone, 1999; Fredriksson-Ahomaa & Korkeala,
2003). It causes yersiniosis, which is usually a mild diarrhoeal
disease. Yersiniae are able to grow over a wide range of
temperatures (0–42 uC) which may result in life-threatening
problems, for example when YeO3-contaminated blood
stored at 4 uC was later infused to patients (Goverde et al.,
1998; Skurnik et al., 1999). The LPS of YeO3 has some
unique features, which were thoroughly analysed at the
compositional (Hoffman et al., 1980; Wartenberg et al.,
1983), structural (Radziejewska-Lebrecht et al., 1994, 1998;
Shashkov et al., 1995; Pinta et al., 2009) and genetic levels
(Skurnik et al., 1995, 1999). A single LPS molecule is
substituted at heptose II of the core octasaccharide either by
a homopolymeric OPS or a so-called outer core hexasac-
charide (Pinta et al., 2012) which actually represents one
remaining repeat of an ancient but no longer expressed OPS.
Another extraordinary feature of YeO3 LPS is that the core
serves as acceptor for ECA (Radziejewska-Lebrecht et al.,
1998).
It was also shown that OPS and ECA coexist in the same
LPS molecules from YeO3 wild-type strains possessing
either full or truncated or no outer core (Muszyński et al.,
2013). The ECA polysaccharide structure consists of linear
trisaccharide repeating units composed of [A3)-a-D-
Fucp4NAc-(1A4)-b-D-ManpNAcA-(1A4)-a-D-GlcpNAc-
(1A]. ECA can either be linked to phosphatidylglycerol
(ECAPG) or to LPS (ECALPS), or is present as a cyclical
molecule without a lipid anchor (ECACYC) that is not
surface-expressed (Kuhn et al., 1988; Castelli & Véscovi,
2011; Gilbreath et al., 2012). Recently, the covalent linkage
between ECA and LPS in Shigella sonnei phase II ECALPS
was characterized (Gozdziewicz et al., 2014). Interestingly,
in certain Ra type E. coli strains only ECALPS, but neither
ECAPG nor ECACYC, were ECA-immunogenic (Kuhn et al.,
1988). By contrast, YeO3 Rc mutants were shown to be
ECA-immunogenic, suggesting that ECA was linked to the
core region (Radziejewska-Lebrecht et al., 1998, 2003;
Kasperkiewicz, 2002; Duda, 2007b).
To elucidate whether the complete core was needed to
express ECALPS in YeO3, we used different deep-rough
mutants with successively truncated core structures. Rabbit
antisera raised against these mutants were shown to possess
anti-ECA antibodies, indicating that ECA was linked to the
Kdo region of YeO3 LPS.
METHODS
Bacterial strains. The bacterial strains used in this study are
described in Table 1. Isolation of the deep-rough LPS mutants used in
this work from the Cat-Mu transposon insertion library constructed
to Y. enterocolitica strain YeO3-c-R1 was described by Pinta et al.
(2012).
Recombinant DNA methods. The galU, waaF and hldE genes of
YeO3 were amplified by PCR and cloned into plasmid pTM100
(Michiels & Cornelis, 1991). The plasmids obtained were mobilized
into the respective mutants and the LPS profiles of the correct
transconjugants were analysed by deoxycholate PAGE (DOC-PAGE)
analysis and silver staining as described by Skurnik et al. (1999).
LPS and ECA preparations (Table 2). LPSPCP preparations of the
deep-rough mutants were prepared as described by Muszyński et al.
(2013) with minor modifications. Briefly, crude LPS obtained from
hot phenol/water extractions was purified by digestion with DNase
and RNase at 37 uC for 10 h, followed by proteinase K treatment for
16 h at 56 uC. After ultracentrifugation (180 000 g, 4 uC, 20 h) and
subsequent phenol/chloroform-light petroleum (PCP) extraction,
pure LPSPCP samples were obtained which were devoid of ECAPG
(Galanos et al., 1969). LPSPCP from Ra mutant YeO3-c-R1 and
ECAPG from S. enterica serovar Montevideo SH94 were used as
controls.
Analytical methods. Chemical composition analyses of LPSPCP
included Kdo and glucosamine determination (Brade et al., 1983;
Kaca et al., 1988), and neutral sugar (Duda et al., 2011) and fatty acid
(Wollenweber & Rietschel, 1990) analyses. GC analysis of alditol
acetates was performed utilizing an HP 5890 (series II) gas chro-
matograph with a flame-ionization detector and a column (30 m 6
2.5 mm 6 0.25 mm; Agilent) of polysilican SPD-5. Helium was used
as carrier gas (70 kPa). The temperature programme in GLC was
3 min/150 uC/3 uC min21/320 uC. Data were integrated and stored
using ChemStation software. GC analysis of methyl esters of fatty
acids was performed in an HP 6890N gas chromatograph with a
flame-ionization detector and a column (30 m 6 0.32 mm 6 0.25 mm;
Agilent) of phenyl methyl siloxane HP-5. Helium was used as carrier gas
(70 kPa). Separations were recorded using ChemStation software. The
temperature programme in GC was 3 min/120 uC/5 uC min21/320 uC/
10 min21.
Mass spectrometry. Electrospray Fourier-transformed ion cyclotron
resonance MS was performed in the negative ion mode using an
APEX Qe-Instrument (Bruker Daltonics) equipped with a 7 T magnet
and a dual Apollo ion source. Mass spectra were acquired in broad
band modes. The samples (~ 10 ng ml21) were dissolved in a
50 : 50 : 0.001 (by vol.) mixture of 2-propanol, water and triethylamine.
The samples were sprayed at a flow rate of 2 ml min21. Capillary
entrance voltage was set to 3.8 kV, and drying gas temperature to
150 uC. Mass spectra were calibrated externally by lipids with known
structure and charged-deconvoluted and the given mass numbers were
referred to the mono-isotopic masses of neutral molecules.
Antibodies. Diluted (1 : 2000) horseradish peroxidase-conjugated
goat anti-rabbit immunoglobulins (P0448; Dako) and alkaline
phosphatase-conjugated goat anti-rabbit antibodies (D0487; Dako)
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were used as secondary antibodies in ELISA and Western blotting
(WB), respectively.
Whole-cell lysates (WCLs). WCLs of bacteria were prepared as
described by Rabsztyn et al. (2011).
Polyvalent antisera. New Zealand white rabbits with no detectable
antibodies against ECA or LPS were immunized with boiled YeO3
deep-rough mutant bacteria. Briefly, the strains were cultivated in
tripticase soy agar (TSA) medium at 22 and 37 uC, washed with sterile
0.85 % NaCl and collected by centrifugation (20 min, 1800 g, 4 uC),
and the bacterial masses obtained were suspended in sterile 0.85 %
NaCl, boiled at 100 uC for 2.5 h and centrifuged as above. The pellets
were resuspended in sterile water and freeze-dried (Alpha; Martin
Christ). Stock suspensions of 5 ml were prepared from the lyophilized
bacterial masses (1 mg of dry bacterial mass per 1 ml of sterile 0.85 %
NaCl). For immunization, 500 ml doses containing 50, 100, 200 and
500 mg of the lyophilized bacterial masses were prepared in sterile
0.85 % NaCl. Rabbits were immunized according to the ‘58 days’
protocol (Swierzko et al., 1993). The polyvalent antisera (approxi-
mately 15 ml per rabbit) obtained 7 days after the last injection were
stored at 220 uC.
Caprylic acid (CA) extraction. Extraction of polyvalent antisera
using CA was performed as described by Pupek (2009), with minor
modifications. One millilitre of the polyvalent antiserum was mixed
with 4 ml of 60 mM acetate buffer (pH 4.0) and the pH of the
mixture was adjusted to 4.5 with 1 M Tris. Thereafter, 125 ml CA was
slowly added, stirring constantly for 30 min. After centrifugation
(130 00 g, 30 min, 4 uC), the supernatant was adjusted to pH 7.4 with
1 M Tris and filtered through a 0.22 mm Millipore filter. The sample
was cooled to 4 uC and 1.53 g (final concentration approximately
1.9 M) ammonium sulfate was added, stirring constantly for 30 min
at 4 uC. After centrifugation (10 000 g, 15 min, 4 uC) the precipitate
was suspended in 500 ml PBS and dialysed against PBS for 18 h. The
buffer was changed and dialysis was continued for 4 h. After
centrifugation (10 000 g, 15 min, 4 uC). supernatant was collected
and stored at 220 uC.
Adsorption of antisera. The polyvalent rabbit antisera were
extensively adsorbed with live YeO3 ECA-negative strain YeO3-c-
OCR-ECA (Table 1) as described by Rabsztyn et al. (2011).
ELISA. The anti-ECA and anti-LPS antibodies were measured using
the ELISA protocol described by Swierzko et al. (1994), with minor
modifications. Briefly, NUNC MaxiSorp 96-microtitre plates were
coated with S. Montevideo SH94 ECAPG (1 mg per well in 50 ml PBS)
or with the YeO3 LPSPCP preparations (5 mg per well in 50 ml PBS)
and incubated at 4 uC for 18 h. The wells were then rinsed twice with
Tris-buffered saline (TBS)+Tween 20 (10 mM Tris, 120 mM NaCl,
0.05 % Tween 20, pH 7.4) containing 1 mM CaCl2 (TBS-Ca
2+) and
incubated for 1 h at 37 uC with 200 ml 0.1 % BSA in TBS-Ca2+. After
washing as above, rabbit antiserum, serially diluted in 0.1 % BSA, was
applied to the wells, each in triplicate. After 1 h of incubation at
Table 1. YeO3 strains used in this work, originating from strain 6471/76 (Skurnik, 1984)
Bacterial strain Description Reference
YeO3-c-R1 Spontaneous rough (OPS-negative) derivative of serotype O : 3 strain 6471/76-c;
Yersinia virulence plasmid-cured
al-Hendy et al. (1992)
YeO3-c-R1-M196 galU : : Cat-Mu. Deep-rough (Rd1 chemotype) Cat-Mu transposon insertion
derivative of YeO3-c-R1, ClmR
This work
YeO3-c-R1-M164 waaF : : Cat-Mu. Deep-rough (Rd2 chemotype), transposon insertion derivative of
YeO3-c-R1, ClmR
This work
YeO3-c-R1-M205 hldE : : Cat-Mu. Deep-rough (Re chemotype) transposon insertion derivative of
YeO3-c-R1, ClmR
This work
YeO3-c-OCR-ECA D(wzx-wbcQ) D(wzzE–wzyE). OPS-, outer core- and ECA-negative derivative
of 6471/76-c, KmR
Rabsztyn et al. (2011)
Table 2. LPS and ECAPG control preparations used in this work
Preparation/strain Description Source/reference
LPSPCP YeO3-c-R1 LPSPCP containing ECALPS from Ra mutant YeO3-c-R1 cultivated
at 22 or 37 uC, free of ECAPG
DM* (Duda, 2007a)
LPSPCP YeO3-c-RfbR7 LPSPCP containing ECALPS from Rc mutant YeO3-c-RfbR7 cultivated
at 22 or 37 uC, free of ECAPG
DM* (Skurnik et al.,
1995)
LPSPCP YeO3-c-R1-M196 LPSPCP containing ECALPS from Rd1 mutant YeO3-c-R1-M196
cultivated at 22, 25 or 37 uC, free of ECAPG
This work
LPSPCP YeO3-c-R1-M164 LPSPCP containing ECALPS from Rd2 mutant YeO3-c-R1-M164
cultivated at 22, 25 or 37 uC, free of ECAPG
This work
LPSPCP YeO3-c-R1-M205 LPSPCP containing ECALPS from Re mutant YeO3-c-R1-M205
cultivated at 22, 25 or 37 uC, free of ECAPG
This work
ECAPG S. Montevideo SH94 ECAPG was obtained from S. Montevideo SH94 cultivated at 37 uC
by Ph/W and PCP extractions
DM* (Männel & Mayer,
1978)
*Department of Microbiology, University of Silesia, Katowice, Poland.
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Fig. 1. Characterization of the LPS of YeO3 mutants. (a) Silver-stained DOC-PAGE profiles of LPSPCP (0.25 mg) and WCL
(2 ml) preparations of YeO3 mutants. Lane 1, WCL of M164; lane 2, WCL of M205; lane 3, WCL of M196; lane 4, LPSPCP of
YeO3-c-R1; lane 5, WCL of YeO3-c-OCR-ECA; lane 6, LPSPCP of M196; lane 7, LPSPCP of M164; lane 8, LPSPCP of M205.
LA, lipid A; IC, inner core; OC, outer core. (b). Structures of LPS from deep-rough mutants: Rd1, M196; Rd2, M164; Re, M205,
and LPSPCP of their parental strain YeO3-c-R1, mutant Ra (Pinta et al., 2012). The dotted line indicates the non-stoichiometric
substitution by ECA of one of two Kdo residues in the shaded rectangle. L,D-Hepp, L-glycero-D-manno-heptopyranose; D,D-
Hepp, D-glycero-D-manno-heptopyranose; Kdo, 3-deoxy-a-D-manno-oct-2-ulosonic acid; D-GlcpNAc, 2-acetamido-2-deoxy-
D-glucopyranose, D-Glcp, D-glucopyranose; D-GalpNAc, 2-acetamido-2-deoxy-D-galactopyranose; D-Galp, a-D-galactopyranose;
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37 uC, wells were washed three times with TBS-Ca2+ buffer and
incubated for 1 h at 37 uC with horseradish peroxidase-conjugated
goat anti-rabbit antibodies, diluted 1 : 2000 in 0.1 % BSA. The wells
were then rinsed as above and the bound secondary antibodies were
detected with 2,29-azino-di(3-ethylbenzthiazolinsulfonate) (Sigma) as
a substrate for peroxidase. After incubation at 37 uC for 30 min, the
reaction was stopped by adding 2 % oxalic acid. The plate was read by
using a Benchmark microplate reader (Bio-Rad) at 405 nm. The last
antibody dilution showing extinction of l40550.2 was taken as a titre.
The experiments were repeated three times.
SDS-PAGE and WB. ECAPG of S. Montevideo SH94 and LPSPCP of
YeO3 strains were separated by SDS-PAGE (Mini-Protean; Bio-Rad)
(Laemmli, 1970). The gels were transferred to PVDF membrane
(Biotrans blotting) and the membrane was processed for WB as
previously described (Towbin et al., 1979; Radziejewska-Lebrecht
et al., 2003).
RESULTS AND DISCUSSION
Characteristics of YeO3 deep-rough Cat-Mu
mutants
The mutant strains YeO3-c-R1-M196, YeO3-c-R1-M164
and YeO3-c-R1-M205 (hereafter M196, M164 and M205,
respectively) were isolated from the Cat-Mu transposon
insertion library based on the lack of an outer core (Pinta
et al., 2012). Identification of the Cat-Mu transposon
insertion sites of the mutants revealed that certain genes
involved in core biosynthesis had been inactivated. M196
carried the Cat-Mu insertion in the galU gene, M164 in the
waaF gene and M205 in the hldE gene. GalU is glucose-1-P
uridylyltransferase, also called UDP-glucose pyrophos-
phorylase, involved in biosynthesis of UDP-glucose.
WaaF is heptosyltransferase II (Gronow et al., 2000) and
HldE is a kinase and ADP-transferase involved in the
biosynthesis of ADP-glycero-manno-heptose (McArthur
et al., 2005). In DOC-PAGE analysis the strains were
found to express deep-rough LPS with different degrees of
core truncation, as shown by their WCL and LPSPCP
profiles (Fig. 1a). The mutants were complemented in trans
by the respective wild-type genes from a plasmid (data not
shown). While the galU : : Cat-Mu and hldE : : Cat-Mu
mutants were fully complemented, the waaF : : Cat-Mu
mutant was only partially so, perhaps reflecting the fact
that waaF is located upstream of the waaC gene encoding
heptosyltransferase I, and thus the mutant might have had
some defect in the latter activity.
Chemical composition of M196, M164 and M205
LPS
Pure LPSPCP preparations from M196, M164 and M205
were obtained at yields of 0.8, 1 and 0.44 %, respectively.
Compositional analysis of these preparations identified
fatty acids [predominantly 14 : 0(3-OH), 12 : 0 and 14 : 0,
with trace 16 : 0], glucosamine and Kdo in all three mutants.
LPSPCP of M164 contained additional L,D-Hep and trace
glucose, whereas LPSPCP of M194 contained additional L-
glycero-D-manno-heptopyranose (L,D-Hep) (1.7 times more
than LPSPCP of M164) and trace D-glycero-D-manno-hepto-
pyranose (D,D-Hep) and glucose. These results were con-
firmed by high-resolution electrospray Fourier-transformed
ion cyclotron resonance MS of the LPSPCP (Fig. 2), recorded
in the negative ion mode. The major molecular mass ion (m/z
2213.0907) on the electrospray ionization (ESI) spectrum of
LPSPCP of M196 (Fig. 2a) corresponded to a molecule
composed of 2 hexosamine (HexN), 2 phosphate (P) residues,
2 Kdo, 2 heptose (Hep) residues, 3 14 : 0(3-OH) and 1 14 : 0
(calculated mass 2213.0991 u). The ion at m/z 2021.0362 of
the spectrum of LPSPCP of M164 (Fig. 2b) was consistent with
a molecule containing 2 HexN, 2 P, 2 Kdo, 1 Hep, 3 14 : 0(3-
OH) and 1 14 : 0 (calculated mass 2021.0391 u). LPSPCP of
M205 was deprived of Hep and composed only of 2 HexN, 2
P, 2 Kdo and 4 14 : 0(3-OH) with or without 1 Ara4N, as
deduced from the presence of two major molecular mass
ions at m/z 1976.0297 and 1844.9727, respectively (calcu-
lated masses 1976.0332 and 1844.9740 u, respectively) (Fig.
2c). The mass spectra possessed additional heterogeneity in
the fatty acids, Kdo, P and Ara4N substitution patterns. In
summary, the compositional and MS analyses of the
respective LPS preparations of deep-rough YeO3 mutants
confirmed the truncations of their core regions (Fig. 1b).
Presence of ECALPS in M196, M164 and M205
We observed a positive reaction of specific anti-ECA
monoclonal antibody 898 (Mab 898) with LPSPCP of all
deep-rough mutants in WB analysis (Fig. 1c). As those
LPSPCP were deprived of ECAPG we assumed that the
reaction was due to the presence of ECALPS, which was
confirmed in further studies (see below).
Detection of anti-ECA- and anti-LPS-specific
antibodies in ELISA
The untreated polyvalent antisera against M196, M164
and M205 were first checked by ELISA for the presence of
D-Sugp, 2-acetamido-2,6-dideoxy-D-xylo-hex-4-ulopyranose; D-Fucp4NAc, 4-acetamido-4,6-dideoxy-D-galactopyranose; D-
ManpNAcA, 2-acetamido-2-deoxy-manno-pyranosuronic acid. (c) SDS-PAGE WB analysis of LPSPCP preparations (3 mg per
lane) of deep-rough mutants of YeO3 cultivated at 22 and 37 6C developed with monoclonal antibody mAb 898 specific for ECA at
1 : 200 dilution. Alkaline phosphatase-conjugated goat anti-mouse antibody was used at 1 : 2000 dilution. Lane 1, YeO3-c-R1
(22 6C); lane 2, YeO3-c-R1 (37 6C); lane 3, YeO3-c-RfbR7 (22 6C); lane 4, YeO3-c-RfbR7 (37 6C); lane 5, M196 (22 6C); lane
6, M196 (37 6C); lane 7, M164 (22 6C); lane 8, M164 (37 6C); lane 9, M205 (22 6C); lane 10, M205 (37 6C); lane 11, LPSPh/W
YeO3-c-OCR-ECA (25 6C); lane 12, ECAPG.
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anti-LPS and anti-ECA antibodies. The untreated antisera
reacted strongly with the ECAPG control with titres .256 000
(anti-M164), 6400 (anti-M196) and 6400 (anti-M205). The
titres of the CA-treated and ECA-specific antisera against
ECAPG had dropped significantly and were 800 for all
samples. When homologous LPSPCP preparations were used
as antigen, the untreated polyvalent antisera showed the same
titre, .256 000. The titres of CA-treated and ECA-specific
antisera against M196 and M205 were 8000 while that for
M164 was 800. In conclusion, the data demonstrated that all
antisera contained both anti-LPS and anti-ECA antibodies,
suggesting that the deep-rough mutants were not only LPS-
but also ECA-immunogenic. CA treatment as well as
adsorption with an ECA-negative strain significantly reduced
the antibody titres against both antigens.
Detection of anti-ECA- and anti-LPS-specific
antibodies in immunoblotting
WB gave more detailed information than ELISA, dem-
onstrating the presence of both anti-LPS and anti-ECALPS
antibodies in antisera. To allow the identification of
antigens migrating in the low (1–5 kDa) and high (10–
50 kDa) molecular mass regions of the gel, 2 mg LPSPCP
corresponding to 2 ml WCL was applied. The WB experi-
ments were performed repeatedly with different dilutions
of antisera, leading to the following representative results.
Antibodies of the untreated polyvalent antisera recognized
antigens in the low-molecular mass regions of YeO3-c-R1
LPSPCP and in the 5–10 kDa region of the WCL of YeO3-
c-OCR-ECA (Fig. 3a, d, g, lanes 1 and 4). The untreated
Fig. 2. The charge-deconvoluted ESI MS spectra of LPSPCP samples from the deep-rough Y. enterocolitica strains. (a) YeO3-
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Fig. 3. WB analyses of rabbit anti-M196 (a–c), anti-M164 (d–f) and anti-M205 (g–i) antisera. (a, d, g) Untreated polyvalent
antisera. (b, e, h) CA-extracted antisera. (c, f, i) Adsorbed (ECA-specific) antisera. The samples applied to the gels are indicated
above the lanes and the lane numbers are indicated below. (p), LPSPCP samples; (w), whole-cell lysate samples. Dilution of
antisera: 1 : 1400. Loading: 2 mg for LPSPCP preparations and ECAPG; 2 ml for WCL.
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anti-M196 antiserum reacted strongly with low-molecular
mass molecules of M196 LPSPCP and WCL (Fig. 3a, lanes 2
and 3), demonstrating the presence of anti-core antibodies
in the serum. The reaction with high-molecular mass
compounds of LPSPCP (Fig. 3a, lane 2) was due to the
presence of ECALPS molecules bound to LPS. Reaction with
ECAPG (Fig. 3a, lane 5) indicated the presence of anti-ECA
antibodies in the serum. The untreated anti-M164 (Fig. 3d,
lanes 2 and 3) and anti-M205 (Fig. 3g, lanes 2 and 3)
antisera gave comparable results to those of anti-M196.
The corresponding CA-treated and ECA-specific antisera
produced similar but weaker patterns with the LPSPCP and
WCL samples (Fig. 3b, c, e, f, h, i, lanes 2 and 3) and reacted
mainly with low-molecular mass molecules. Moreover, these
antisera had completely lost reactivity with the WCL of
YeO3-c-OCR-ECA (Fig. 3b, c, e, f, h, i, lane 4), suggesting
that the CA treatment had effectively removed the IgM
antibodies that had apparently made up the majority of the
anti-LPS, but also some of the anti-ECA antibodies (Fig. 3b,
e, h, lanes 1–3). The results also demonstrated that the
adsorption with live bacteria was successful as no anti-LPS
antibodies were detected in the anti-ECA-specific sera (Fig.
3c, f, i, lane 4), although some anti-ECAPG antibodies were
also removed (Fig. 3c, f, i, lane 5). We speculate that the anti-
ECA antibodies in adsorbed antisera were responsible for the
relatively weaker immunostaining of the LPSPCP and WCL
preparations (Fig. 3c, f, i, lanes 2 and 3) than was the
corresponding staining of the polyvalent antisera (Fig. 3a, d,
g, lanes 2 and 3).
WB using ECAPG as antigen showed that all the polyvalent
antisera contained anti-ECAPG antibodies, although the
staining did not reveal the typical ladder-like banding
profile. Instead, the antibodies recognized a molecule
located in the low-molecular mass region and/or one or
two sharp bands higher up in the gel (Fig. 3a, d, g, lane 5).
The CA-treated anti-M196 and anti-M164 antisera resulted
in one sharp band in the low-molecular mass region (Fig.
3b, e, lane 5), while CA-treated anti-M205 recognized in
addition a faster-migrating compound (Fig. 3h, lane 5),
indicating that CA extraction led to partial loss of anti-ECA
antibodies.
Interestingly, anti-M205 antiserum also reacted with
ECAPG (Fig. 3i, lane 5), demonstrating that the Kdo region
of LPS is probably an acceptor for ECA. This conclusion is
further supported by the presence of ECALPS in LPSPCP of
M205 and by the finding that free LA of YeO3 was not
ECA-positive (data not shown).
WB analysis of all the anti-LPSPCP antisera revealed some
positive reactions with the adsorbed sera as a smear in the
high-molecular mass region. As the bacteria lack OPS, the
smear was probably a tailing artefact, especially as some
tailing could also be seen in the WCL preparations. The
very weak reactivity of the anti-ECA antibodies against
ECAPG again demonstrated that the ECA epitope(s)
present in ECALPS are distinct from the ECA epitope(s)
in ECAPG, in accordance with the results of Rabsztyn and
co-workers (Rabsztyn et al., 2011).
In summary, we clearly demonstrated that anti-M196,
anti-M164 and anti-M205 antisera contained anti-ECA
antibodies, showing that these deep-rough strains are ECA-
immunogenic. The WB results furthermore suggested that
the ECA substitution in YeO3 LPS is located in the Kdo
region, although structural studies will be required to
confirm this.
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Prastowska. Warsaw: Polish Scientific Publishers [in Polish].
Rabsztyn, K., Kasperkiewicz, K., Duda, K. A., Li, C.-M., Łukasik, M.,
Radziejewska-Lebrecht, J. & Skurnik, M. (2011). Characterization of
anti-ECA antibodies in rabbit antiserum against rough Yersinia
enterocolitica O : 3. Biochemistry (Mosc) 76, 832–839.
Radziejewska-Lebrecht, J., Shashkov, A. S., Stroobant, V.,
Wartenberg, K., Warth, Ch. & Mayer, H. (1994). The inner core
region of Yersinia enterocolitica Ye75R (O : 3) lipopolysaccharide. Eur
J Biochem 221, 343–351.
Radziejewska-Lebrecht, J., Skurnik, M., Shashkov, A. S., Brade, L.,
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